NO971495D0 - Svekkede virus og fremgangsmåte til deres fremstilling - Google Patents

Svekkede virus og fremgangsmåte til deres fremstilling

Info

Publication number
NO971495D0
NO971495D0 NO971495A NO971495A NO971495D0 NO 971495 D0 NO971495 D0 NO 971495D0 NO 971495 A NO971495 A NO 971495A NO 971495 A NO971495 A NO 971495A NO 971495 D0 NO971495 D0 NO 971495D0
Authority
NO
Norway
Prior art keywords
processes
preparation
attenuated viruses
attenuated
viruses
Prior art date
Application number
NO971495A
Other languages
English (en)
Other versions
NO971495L (no
Inventor
Jonathan W Nyce
Original Assignee
Univ East Carolina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ East Carolina filed Critical Univ East Carolina
Publication of NO971495D0 publication Critical patent/NO971495D0/no
Publication of NO971495L publication Critical patent/NO971495L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16051—Methods of production or purification of viral material
NO971495A 1994-10-07 1997-04-02 Svekkede virus og fremgangsmåte til deres fremstilling NO971495L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/319,974 US20030104576A1 (en) 1994-10-07 1994-10-07 Dna construct, composition, formulations & methods for making the construct & for modulating expression
PCT/US1995/013219 WO1996011280A1 (en) 1994-10-07 1995-10-05 Attenuated viruses and method of making the same

Publications (2)

Publication Number Publication Date
NO971495D0 true NO971495D0 (no) 1997-04-02
NO971495L NO971495L (no) 1997-05-26

Family

ID=23244339

Family Applications (1)

Application Number Title Priority Date Filing Date
NO971495A NO971495L (no) 1994-10-07 1997-04-02 Svekkede virus og fremgangsmåte til deres fremstilling

Country Status (10)

Country Link
US (1) US20030104576A1 (no)
EP (1) EP0784692A1 (no)
JP (1) JPH10507077A (no)
KR (1) KR970706399A (no)
CN (1) CN1169161A (no)
CA (1) CA2201487A1 (no)
MX (1) MX9702524A (no)
NO (1) NO971495L (no)
NZ (1) NZ295070A (no)
WO (1) WO1996011280A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6982253B2 (en) 2002-06-05 2006-01-03 Supergen, Inc. Liquid formulation of decitabine and use of the same
ES2322172T3 (es) * 2004-05-26 2009-06-17 Biovaxim Limited Composiciones que comprenden agentes desmetilantes como potenciadores de la inmunoterapia para el tratamiento de infecciones cronicas y enfermedades neoplasicas y metodos para tratar las mismas.
US7250416B2 (en) 2005-03-11 2007-07-31 Supergen, Inc. Azacytosine analogs and derivatives
US7700567B2 (en) 2005-09-29 2010-04-20 Supergen, Inc. Oligonucleotide analogues incorporating 5-aza-cytosine therein
CN101045946B (zh) * 2007-04-29 2010-09-29 深圳市疾病预防控制中心 Hiv基因检测芯片及其制备方法
AR063866A1 (es) * 2007-11-20 2009-02-25 Consejo Nac Invest Cient Tec Un procedimiento para la obtencion de cepas virales atenuadas
EP2451950B9 (en) 2009-07-06 2016-11-23 Variation Biotechnologies Inc. Methods for preparing vesicles and formulations produced therefrom
US9907746B2 (en) 2009-07-06 2018-03-06 Variation Biotechnologies, Inc. Methods for preparing vesicles and formulations produced therefrom
CN103501811B (zh) * 2011-01-13 2016-03-30 变异生物技术公司 用于治疗病毒感染的组合物和方法
CN108635367B (zh) 2011-08-30 2020-08-21 阿斯泰克斯制药公司 地西他滨衍生物制剂
CN104302323A (zh) 2012-01-12 2015-01-21 变异生物技术公司 用于治疗病毒感染的组合物和方法
EP4008354A1 (en) 2012-01-27 2022-06-08 Variation Biotechnologies Inc. Methods and compositions for therapeutic agents
ES2784351T3 (es) * 2015-05-18 2020-09-24 Calimmune Inc Métodos de discriminación entre el VIH-1 y vectores de lentivíricos
AU2016287585B2 (en) 2015-07-02 2020-12-17 Otsuka Pharmaceutical Co., Ltd. Lyophilized pharmaceutical compositions
MX2020001233A (es) 2017-08-03 2020-07-20 Otsuka Pharma Co Ltd Compuesto farmaceutico y metodos de purificacion del mismo.
CN113186353A (zh) * 2021-05-28 2021-07-30 杭州晶佰生物技术有限公司 针对c型逆转录病毒的数字pcr检测用引物及检测方法

Also Published As

Publication number Publication date
CA2201487A1 (en) 1996-04-18
NO971495L (no) 1997-05-26
JPH10507077A (ja) 1998-07-14
MX9702524A (es) 1998-02-28
AU707782B2 (en) 1999-07-22
NZ295070A (en) 1999-11-29
CN1169161A (zh) 1997-12-31
US20030104576A1 (en) 2003-06-05
AU3832795A (en) 1996-05-02
EP0784692A1 (en) 1997-07-23
KR970706399A (ko) 1997-11-03
WO1996011280A1 (en) 1996-04-18

Similar Documents

Publication Publication Date Title
NO20004104L (no) Preparater omfattende virus og fremgangsmater for konsentrering av viruspreparater
NO971495L (no) Svekkede virus og fremgangsmåte til deres fremstilling
NO985196L (no) Dispergerbare makromolekylblandinger og fremgangsmÕter for deres fremstilli
DK0909327T3 (da) Erythromyciner og fremgangsmåder til deres fremstilling
NO922949D0 (no) Forbindelser og fremgangsmaater for inhibering av hiv- og beslektede virus
NO983965D0 (no) Polymer-organoleire-kompositter og deres fremstilling
NO961160L (no) Cykliske forbindelser, deres fremstilling og anvendelse
DK0740668T3 (da) Tetracykliske derivater, fremgangsmåde til deres fremstilling og deres anvendelse
NO922275D0 (no) Aryletere, deres fremstilling og fremgangsmaate for behandling
AU7501898A (en) Live attenuated virus vaccines for equine encephalitis viruses
DK0991666T3 (da) Alfa-1-antitrypsin-præparat og fremgangsmåde til fremstilling heraf
DK1001684T3 (da) Afvandede kartoffelstykker og fremgangsmåde til deres fremstilling
NO943794D0 (no) 4-difenylmethylpiperidinderivater, og fremgangsmåte for deres fremstilling
NO985248L (no) Indolylpyrrolydenmetylpyrrolderivater og fremgangsmÕte for deres fremstilli
IS5777A (is) Bóluefnisvakið lifrarbólgu B veiruafbrigði og notkun þess
NO941517L (no) 2-amino-4-kinolin-dihydropyridiner, fremgangsmåter for deres fremstilling og deres anvendelse
NO983472D0 (no) Taxoider, deres fremstilling og farmas°ytiske preparater inneholdende taxoidene
NO931246D0 (no) Sammensetninger for behandling av infeksjon og sykdom foraarsaket av hepatites b virus (hbv)
DK1131414T3 (da) Stabile, svækkede rabiesvirusmutanter og levende vacciner deraf
NO911047L (no) Labdaner og fremgangsmaate for deres fremstilling.
NO991227D0 (no) PTX-sensitive G-proteiner, deres fremstilling og bruk
BR9506962A (pt) Cultura seletiva de virus
IL116117A0 (en) Papaya ringspot virus replicase gene
ZA985117B (en) Method of attenuating viruses.
DE69824881D1 (de) Kompakte replikons des epstein-barr-virus.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application